COVID-19 News Updates

The researchers found that B cells targeted against SARS-CoV-2 persisted in the germinal centres - like boot camps where B cells are trained to make ever-better-quality antibodies - of all participants for months. Even six months after vaccination, 10 out of 15 people still had B cells in their germinal centres.

With the changing epidemiology of the pandemic globally and in India, existing guidelines aimed at minimising the transmission and circulation of the virus have been reviewed and updated. The Union Ministry of Health accordingly revised its guidelines for international arrivals on February 10, he stated.

Meanwhile, the weekly positivity rate currently stands at 3.32 per cent while the daily positivity rate has risen to 2.45 per cent.

The US continues to be the worst-hit country with the world's highest number of cases and deaths at 78,036,352 and 925,438, according to the CSSE.

According to BIGHIT, V was in contact with the other members of the band on Saturday but everyone was wearing masks.

Active COVID-19 Cases In Country Decline To 4,23,127

US continues to be the worst-hit country with the world's highest number of cases and deaths at 77,919,113 and 922,474, according to the CSSE.

In an application sent to the DCGI on February 9, Srinivas Kosaraju, the head of Quality and Regulatory Affairs of Biological E Limited said the firm had received approval for conducting phase 2/3 clinical study of Corbevax among children and adolescents aged 5-18 years in September.

Deltacron as first reported from Cyprus last month, but was later dismissed and put down to sample contamination.

Meanwhile, at least 20 more people have succumbed to COVID in the State taking the overall death toll to 8,904.

The daily positivity rate was recorded at 3.19 per cent. The weekly positivity rate stood at 3.99 per cent, the ministry said.

The second worst-hit country in terms of cases is India (42,631,421 infections and 508,665 deaths), followed by Brazil (27,492,904 infections and 638,673 deaths).

According to the guidelines, all the passengers will show self-declaration form on arrival at the airport. The passengers found to be symptomatic during screening will be immediately isolated and taken to medical facility under health protocol.

Based on the no-objection certificate, Biological E has initiated the clinical study in October 2021 and has evaluated the available safety and immunogenicity results of the ongoing phase 2/3 study, which indicated that the vaccine is safe and immunogenic.

With the administration of more than 49.16 lakh vaccine doses in the last 24 hours, India's Covid-19 vaccination coverage has exceeded 172.81 crore as per the health ministry report on Sunday morning.